Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
about
Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysisContribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.Bringing Transparency to Medicine: Exploring Physicians' Views and Experiences of the Sunshine Act.Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.Types and Distribution of Payments From Industry to Physicians in 2015.President's Address: Physicians and the Pharmaceutical Industry.Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.Opioid Prescribing: How Well Do We Know Ourselves?Cross-sectional Analysis of the Relationship between Paranasal Sinus Balloon Catheter Dilations and Industry Payments among Otolaryngologists.Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.Patterns and predictors of physician adoption of new cardiovascular drugs.A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.Influence of overstated abstract conclusions on clinicians: a web-based randomised controlled trial.Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest: Challenges and Solutions.Gynaecologists and industry: ain't no sunshine.Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.Powered by Sunshine: Next Steps for Making Transparency Matter.Industry support of physician education in the USA.The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study.Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review.Towards Patient-Centered Conflicts of Interest Policy.Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.Industry Payments to Physicians for Opioid Products, 2013-2015.The Receipt of Industry Payments is Associated with Prescribing Promoted Alpha-Blockers and Overactive Bladder Medications.Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.Investigator bias and the PACE trial.Having Their Cake and Eating It Too: Physician Skepticism of the Open Payments Program.Geographical variation in anti-diabetic prescribing in Ireland in 2013 and 2014: a cross-sectional analysis.The Effects of the Sunshine Act: What Can and Should We Expect?Getting more light into the dark room of editorial conflicts of interest.Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.Conflicts of interest of editors of medical journals.Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts
P2860
Q29994595-AC5A693C-3B28-4099-86AB-5A9AA85982F5Q33815256-D0AF1095-287A-4A91-9569-279C1AB02009Q38657817-D28F8535-B98D-4272-A4A0-11C9634E0C2DQ38767427-613BCF3B-C583-4E6A-AC09-B53DAF64D095Q38796535-40922EDF-D5FF-44FF-92CD-05AF0069BDEAQ38808785-FCED5108-CF6C-415F-A14A-6FAE2A1D2418Q38808789-89F3FED3-0FEE-4660-B734-D1D2C618DB02Q41112143-E196777F-E4D3-41F0-836F-FA39717A9D75Q41677333-E2F58D55-1323-448E-A31B-F642D25762A6Q42215595-22ED43BF-093A-494B-92BF-C0742BAC5AB4Q42335424-3299EF30-23E3-459C-97A1-064FFCE0E6CDQ42689858-1D2891E3-701F-4061-BF0B-E8776A689C32Q42697903-CC6D12FE-0B16-4F66-9F37-E0AD5BDCA7DAQ42699082-B0AED138-687B-47F9-BF87-AA30988403CDQ46590970-A9598049-40A8-4F54-8E82-74C0397AAEA7Q47121834-FD413344-2688-4FAF-B25D-283309E52AAEQ47141975-E11F4183-3922-459F-A9C2-4056916C071BQ47186805-C9069C31-0501-45A4-B6B0-EA1B831EB997Q47657946-A985A646-6300-474D-B9A1-FF91EE957392Q47738447-130181D5-278A-4E4C-B261-063812E0AE52Q47852975-4DA6F2D6-7AAE-4AE1-8423-B82C68F366AEQ48107584-FEF15761-E2DA-4B9C-8082-3CC5B6252432Q48361892-78F8B83C-5EA6-486D-8D44-E0C7EF770AF8Q49572096-C42A8CC9-4914-45EA-B117-9F250C0A00EFQ50133431-1F617882-BCD4-47B5-886C-FD71AEBC8459Q50219873-9E089E59-ED7C-4BEF-B552-D685E5F6E2E6Q50351538-2B01C5CF-D19B-46D7-ADBC-C05AD8A6C443Q52313786-C349AA18-25A4-4025-A0F0-2A0E3C72238EQ52572355-235FF9D6-5A67-44F9-B299-8F7C4459A8F3Q52612467-5E475CC6-827D-4DC2-A78D-C46D3BF93051Q53253104-B4F8B0F8-DBE3-4717-A224-40365F9F7C13Q53271775-B4C6F2FD-7ECB-468A-B59E-CF9A695D7402Q53313336-2D828FD8-DCE8-43C8-968E-3162250921A6Q54683040-FB600F50-2C80-4691-9ADD-04BA0219004FQ55040246-4E67D726-5959-487C-BD13-989D70EA3056Q55342152-75E26FEF-D210-436A-81F1-1DDCECB400DBQ55363483-E2D23709-0D72-486E-96A4-F0958BABD336Q57806288-C4126042-8C79-4C60-9EBA-79B50395F5ED
P2860
Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@ast
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@en
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@nl
type
label
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@ast
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@en
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@nl
prefLabel
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@ast
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@en
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@nl
P2093
P1476
Pharmaceutical Industry–Sponso ...... rns for Medicare Beneficiaries
@en
P2093
Chien-Wen Tseng
Colette DeJong
Grace A. Lin
R. Adams Dudley
Thomas Aguilar
W. John Boscardin
P356
10.1001/JAMAINTERNMED.2016.2765
P577
2016-08-01T00:00:00Z